| Code | Description | Claims | Beneficiaries | Total Paid |
| H0039 |
Assertive community treatment, face-to-face, per 15 minutes |
13,028 |
1,972 |
$3.65M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
26,008 |
25,107 |
$3.41M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,255 |
5,776 |
$495K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,914 |
2,818 |
$402K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,811 |
2,723 |
$290K |
| T1015 |
Clinic visit/encounter, all-inclusive |
10,327 |
9,076 |
$257K |
| 80053 |
Comprehensive metabolic panel |
23,459 |
21,650 |
$187K |
| G0378 |
Hospital observation service, per hour |
373 |
329 |
$140K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,997 |
5,534 |
$113K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,178 |
5,019 |
$99K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,026 |
20,403 |
$87K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,588 |
3,473 |
$82K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,062 |
1,993 |
$82K |
| 71046 |
Radiologic examination, chest; 2 views |
8,506 |
8,230 |
$82K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
895 |
883 |
$75K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
955 |
932 |
$45K |
| 0001A |
|
1,263 |
1,261 |
$45K |
| 87428 |
|
1,321 |
1,312 |
$45K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,073 |
6,754 |
$44K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
389 |
376 |
$34K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
835 |
721 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
906 |
852 |
$32K |
| 80061 |
Lipid panel |
2,970 |
2,898 |
$32K |
| 0002A |
|
768 |
766 |
$31K |
| 80050 |
General health panel |
729 |
718 |
$27K |
| 84484 |
|
3,852 |
3,569 |
$27K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,773 |
1,712 |
$26K |
| 87081 |
|
4,468 |
4,415 |
$24K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,308 |
2,026 |
$23K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
473 |
466 |
$19K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
243 |
242 |
$19K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
767 |
743 |
$18K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
685 |
678 |
$18K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
220 |
210 |
$17K |
| 81001 |
|
8,462 |
8,152 |
$17K |
| 83690 |
|
4,355 |
4,206 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
891 |
820 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,663 |
1,992 |
$12K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,584 |
1,340 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,815 |
1,597 |
$10K |
| 0004A |
|
231 |
231 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
154 |
153 |
$9K |
| 86001 |
|
2,209 |
2,159 |
$9K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
253 |
249 |
$9K |
| 95811 |
|
23 |
23 |
$9K |
| 81025 |
|
2,855 |
2,774 |
$8K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
237 |
218 |
$8K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
34 |
33 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,594 |
1,491 |
$8K |
| 85027 |
|
2,084 |
1,636 |
$8K |
| 87490 |
|
388 |
368 |
$7K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
64 |
64 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,520 |
1,477 |
$7K |
| 82728 |
|
795 |
767 |
$7K |
| 87797 |
|
319 |
305 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
106 |
95 |
$6K |
| 82607 |
|
743 |
726 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
52 |
52 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
230 |
229 |
$6K |
| 83540 |
|
856 |
823 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
215 |
205 |
$5K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
61 |
61 |
$5K |
| 86803 |
|
314 |
300 |
$5K |
| 93971 |
|
101 |
100 |
$4K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
167 |
95 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
12,461 |
11,056 |
$4K |
| 0124A |
|
83 |
83 |
$3K |
| 0071A |
|
82 |
82 |
$3K |
| 84439 |
|
558 |
535 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
89 |
83 |
$3K |
| 86140 |
|
1,364 |
1,245 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
238 |
216 |
$3K |
| 93017 |
|
147 |
146 |
$3K |
| 0072A |
|
69 |
68 |
$3K |
| 64635 |
|
18 |
12 |
$3K |
| 82570 |
|
389 |
374 |
$3K |
| 80076 |
|
385 |
358 |
$3K |
| 71250 |
|
68 |
67 |
$3K |
| 83550 |
|
759 |
729 |
$3K |
| 86618 |
|
140 |
135 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
25 |
25 |
$3K |
| 83735 |
|
567 |
452 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
563 |
421 |
$2K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
12 |
12 |
$2K |
| 93970 |
|
127 |
126 |
$2K |
| 84702 |
|
180 |
154 |
$2K |
| 87186 |
|
499 |
474 |
$2K |
| 85610 |
|
1,259 |
890 |
$2K |
| 88342 |
|
70 |
69 |
$2K |
| 83880 |
|
198 |
183 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
72 |
71 |
$2K |
| 83721 |
|
246 |
241 |
$2K |
| 76830 |
Ultrasound, transvaginal |
58 |
58 |
$2K |
| 85651 |
|
767 |
698 |
$2K |
| 76536 |
|
51 |
51 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
74 |
73 |
$2K |
| 82043 |
|
274 |
264 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
33 |
33 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
63 |
61 |
$2K |
| 0003A |
|
37 |
37 |
$2K |
| 73030 |
|
167 |
156 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
39 |
38 |
$1K |
| 85730 |
|
509 |
470 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
66 |
65 |
$1K |
| 76801 |
|
42 |
35 |
$1K |
| 86038 |
|
105 |
105 |
$1K |
| 72110 |
|
146 |
144 |
$1K |
| 87077 |
|
360 |
343 |
$1K |
| 85379 |
|
311 |
273 |
$1K |
| 76642 |
|
36 |
35 |
$1K |
| 82565 |
|
291 |
261 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
46 |
26 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
28 |
14 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,154 |
1,942 |
$1K |
| 86480 |
|
14 |
14 |
$1K |
| 73610 |
|
168 |
156 |
$1K |
| 84153 |
|
51 |
51 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
128 |
119 |
$1K |
| 82746 |
|
151 |
145 |
$1K |
| 83655 |
|
98 |
94 |
$1K |
| 84145 |
|
172 |
156 |
$977.95 |
| 87340 |
|
72 |
72 |
$930.54 |
| 88313 |
|
29 |
29 |
$899.34 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
24 |
24 |
$888.36 |
| 86850 |
|
279 |
213 |
$858.66 |
| 73564 |
|
101 |
98 |
$857.31 |
| 87075 |
|
101 |
95 |
$841.96 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
17 |
13 |
$816.62 |
| 73630 |
|
194 |
186 |
$787.39 |
| 82550 |
|
194 |
177 |
$781.41 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
15 |
15 |
$761.22 |
| 73560 |
|
90 |
89 |
$737.16 |
| 84403 |
|
27 |
27 |
$735.56 |
| 97162 |
|
40 |
38 |
$734.71 |
| 87070 |
|
145 |
134 |
$717.49 |
| 84520 |
|
184 |
166 |
$711.82 |
| 82948 |
|
880 |
502 |
$696.76 |
| 73502 |
|
74 |
70 |
$659.80 |
| 84146 |
|
31 |
30 |
$651.36 |
| 73130 |
|
118 |
112 |
$645.03 |
| 84550 |
|
111 |
95 |
$631.13 |
| 84100 |
|
130 |
92 |
$627.41 |
| 95806 |
|
14 |
13 |
$603.02 |
| 83615 |
|
114 |
74 |
$594.75 |
| 87653 |
|
16 |
16 |
$589.59 |
| 93976 |
|
18 |
18 |
$548.29 |
| 87205 |
|
168 |
156 |
$536.34 |
| 87481 |
|
13 |
13 |
$530.96 |
| 0054A |
|
13 |
13 |
$528.80 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25 |
25 |
$509.49 |
| 86900 |
|
330 |
261 |
$485.07 |
| 80055 |
|
41 |
39 |
$477.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
24 |
24 |
$467.30 |
| 94729 |
|
29 |
29 |
$401.72 |
| 96376 |
|
78 |
55 |
$380.55 |
| 72050 |
|
29 |
28 |
$375.14 |
| 94726 |
|
29 |
29 |
$369.21 |
| 86160 |
|
12 |
12 |
$363.51 |
| 82947 |
|
613 |
479 |
$358.35 |
| 73110 |
|
66 |
63 |
$338.75 |
| 83605 |
|
92 |
86 |
$328.00 |
| J3490 |
Unclassified drugs |
1,568 |
1,170 |
$313.21 |
| 71045 |
Radiologic examination, chest; single view |
86 |
84 |
$311.26 |
| 99153 |
Mod sedat endo service >5yrs |
138 |
124 |
$302.94 |
| 80178 |
|
44 |
39 |
$289.94 |
| 87088 |
|
47 |
46 |
$289.02 |
| A9505 |
Thallium tl-201 thallous chloride, diagnostic, per millicurie |
37 |
37 |
$279.36 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
665 |
462 |
$276.46 |
| 93880 |
|
15 |
15 |
$268.51 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
49 |
49 |
$240.79 |
| 84460 |
|
40 |
40 |
$232.84 |
| J2704 |
Injection, propofol, 10 mg |
1,109 |
895 |
$229.85 |
| 84480 |
|
29 |
28 |
$228.83 |
| 82950 |
|
36 |
36 |
$224.70 |
| 86901 |
|
65 |
51 |
$220.86 |
| 93226 |
|
12 |
12 |
$219.09 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
500 |
442 |
$211.84 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
25 |
19 |
$207.43 |
| 83001 |
|
12 |
12 |
$207.04 |
| 88304 |
|
105 |
92 |
$200.72 |
| 94644 |
|
14 |
12 |
$197.89 |
| 99152 |
|
156 |
129 |
$195.92 |
| 82248 |
|
32 |
29 |
$192.13 |
| 84450 |
|
37 |
33 |
$184.04 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
153 |
147 |
$183.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,542 |
2,226 |
$169.74 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
20 |
12 |
$155.41 |
| 74018 |
|
12 |
12 |
$149.02 |
| 84156 |
|
39 |
36 |
$148.54 |
| 73080 |
|
26 |
24 |
$141.87 |
| 82140 |
|
36 |
31 |
$137.75 |
| 82977 |
|
19 |
15 |
$132.20 |
| 86431 |
|
16 |
16 |
$124.05 |
| 87185 |
|
34 |
31 |
$120.14 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
12 |
12 |
$119.88 |
| 84703 |
|
154 |
147 |
$118.91 |
| 93225 |
|
12 |
12 |
$100.58 |
| 80164 |
|
13 |
12 |
$94.69 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
765 |
536 |
$92.08 |
| 85045 |
|
20 |
14 |
$88.85 |
| 86592 |
|
27 |
27 |
$87.04 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,984 |
1,439 |
$84.55 |
| 87184 |
|
14 |
13 |
$76.88 |
| 85018 |
|
45 |
39 |
$75.72 |
| 84436 |
|
12 |
12 |
$66.43 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,707 |
2,162 |
$63.44 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
893 |
760 |
$59.63 |
| J1644 |
Injection, heparin sodium, per 1000 units |
196 |
107 |
$51.92 |
| A6252 |
Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
86 |
50 |
$51.74 |
| 87147 |
|
14 |
14 |
$42.63 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
76 |
58 |
$38.79 |
| A6021 |
Collagen dressing, sterile, size 16 sq. in. or less, each |
29 |
14 |
$35.28 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
212 |
182 |
$32.88 |
| 85014 |
|
14 |
14 |
$28.41 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,941 |
1,550 |
$25.29 |
| A6452 |
High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard |
102 |
39 |
$21.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
98 |
79 |
$19.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
118 |
97 |
$15.61 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
49 |
38 |
$13.53 |
| 76937 |
|
15 |
13 |
$12.75 |
| 94060 |
|
17 |
17 |
$12.65 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
66 |
39 |
$11.92 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
15 |
12 |
$5.58 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
323 |
259 |
$3.82 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$2.28 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
32 |
25 |
$0.66 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
114 |
92 |
$0.20 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
27 |
12 |
$0.13 |
| 3044F |
|
13 |
13 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
22 |
17 |
$0.00 |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
30 |
13 |
$0.00 |
| 3051F |
|
38 |
37 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
14 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
44 |
42 |
$0.00 |
| 90715 |
|
27 |
26 |
$0.00 |